Apolipoprotein E Knockout Models
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
338-351
Author(s):
Genovefa Kolovou, Katherine Anagnostopoulou, Dimitri P. Mikhailidis and Dennis V. Cokkinos
Role of Inflammation in Diabetic Nephropathy
Journal:
Current Diabetes Reviews
Volume:
4
Page:
10-17
Author(s):
Oliver Lenz, Alessia Fornoni, Adeel Ijaz and Thor Tejada
Pathogenesis of the Podocytopathy and Proteinuria in Diabetic Glomerulopathy
Journal:
Current Diabetes Reviews
Volume:
4
Page:
39-45
Author(s):
Fuad N. Ziyadeh and Gunter Wolf
Efficacy of Pentoxifylline in the Management of Microalbuminuria in Patients with Diabetes
Journal:
Current Diabetes Reviews
Volume:
4
Page:
55-62
Author(s):
Martha Rodriguez-Moran and Fernando Guerrero-Romero
Prevention of Macrovascular Disease in Type 2 Diabetic Patients: Blockade of the Renin-Angiotensin-Aldosterone System
Journal:
Current Diabetes Reviews
Volume:
4
Page:
63-78
Author(s):
G. Neil Thomas and Brian Tomlinson
Receptor for Advanced Glycation End Products (RAGE): A Novel Therapeutic Target for Diabetic Vascular Complication
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
487-495
Author(s):
Sho-ichi Yamagishi, Kazuo Nakamura, Takanori Matsui, Yoshihiro Noda and Tsutomu Imaizumi
Role of Oxidative Stress in the Development of Vascular Injury and its Therapeutic Intervention by Nifedipine
Journal:
Current Medicinal Chemistry
Volume:
15
Page:
172-177
Author(s):
Sho-ichi Yamagishi, Kazuo Nakamura and Takanori Matsui
Criteria for Creating and Assessing Mouse Models of Diabetic Neuropathy
Journal:
Current Drug Targets
Volume:
9
Page:
3-13
Author(s):
Eva L. Feldman, Kelli A. Sullivan, Stephen I. Lentz and John L. Roberts Jr.
Aldose Reductase, Still a Compelling Target for Diabetic Neuropathy
Journal:
Current Drug Targets
Volume:
9
Page:
14-36
Author(s):
Peter J. Oates
The Potential Role of Angiotensin Converting Enzyme and Vasopeptidase Inhibitors in the Treatment of Diabetic Neuropathy
Journal:
Current Drug Targets
Volume:
9
Page:
77-84
Author(s):
Mark A. Yorek